Cancer

Article	Citations
Issue Information	1548
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people	328
Issue Information	229
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality	183
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries	136
Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”	135
Children and adolescents with hematologic cancers deserve better end‐of‐life care	118
Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer	117
The critical need to implement and utilize patient‐reported measures of function in cancer care delivery	107
	106
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis	104
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?	98
The economics of advanced and unresectable hepatocellular carcinoma	89
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia	87
Potential of circulating tumor DNA to refine immunotherapy	75
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders	73
Childhood cancer mortality trends in the Americas and Australasia: An update to 2017	68
Updated American Cancer Society lung cancer screening guidelines	67
Issue Information	57
Epistemic equity in oncology: Opportunities to leverage patient‐centric implementation in clinical trial design	57
What enhanced recovery means for patients with cancer undergoing surgery	55
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents	53
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma	53
	53
Issue Information	50

Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer	50
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas	50
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer	48
New standard of care for multiple myeloma?	48
	48
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?	48
Erratum to “Chimeric antigen receptor–based immunotherapy in breast cancer: Recent progress in China”	48
Top advances of the year: Cervical cancer	47
Characteristics of clinical trials of new oncology drugs approved in China	47
Erratum to “Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study”	46
Erratum to “Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation”	46
Exemptions to state laws regulating opioid prescribing for patients with cancer‐related pain: A summary	46
Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study	43
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial	43
Reply to “Enhancing the role of social work in managing cancer risks among LGBTQ+ populations” and “The urgency of systematically acquiring sexual orientation and gender identity data (SOGI) to ensure	43
New test for detecting cervical adenocarcinoma	43
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana	43
International perspectives on the development, application, and evaluation of a multicancer early detection strategy	43
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study	42
Accelerated approval of multiple myeloma therapies	42
Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion	42
Midlife baseline prostate‐specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality	41
Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy	40
Erratum to “Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study”	40
Implantable cardioverter defibrillators in people dying with cancer: A SEER‐Medicare analysis of ICD prevalence and association with aggressive end‐of‐life care	39
The Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer (CISTO) study: Lessons learned about management and patient enrollment in a large, pragmatic, patient‐centere	39
	38
Evaluation of headache in patients with cancer	38
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer	38
Worldwide trend in human papillomavirus–attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030	38
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1	37
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies	37
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network	37
Oncologic outcomes of human papillomavirus–associated oropharynx carcinoma treated with surgery alone: A 12‐institution study of 344 patients	36
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation	36
	36
Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)	35
Association between visceral adiposity index and cancer risk in the UK Biobank cohort	35
Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non‐Indigenous men in a universal health care system	35
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases	35
What’s the reality for CDK4/6 inhibitors: Clinical trials or real‐world evidence?	35
Active Living After Cancer: Adaptation and evaluation of a community‐based physical activity program for minority and medically underserved breast cancer survivors	34
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study	34
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study	34
Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial	34
A single‐arm, multicenter, open‐label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer	34
Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data	34
Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials	34
Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery	33
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries	33

Aspirin but not statins is inversely related to gastric cancer with a duration–risk effect: Results from the Stomach Cancer Pooling Project Consortium	33
Smoking cessation services and shared decision‐making practices among lung cancer screening facilities: A cross‐sectional study	32
Recent histone deacetylase inhibitors in cancer therapy	32
Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing	32
“Cancer Statistics, 2025” provides data on cancer occurrence and outcomes	32
Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme	32
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls	31
Long‐term follow‐up of a phase 2 study of all‐trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia	31
Top advances of the year: Neoadjuvant immunotherapy in melanoma	31
Serum of interleukin‐6 and procalcitonin as early diagnostic markers for the identification of poor hematopoietic reconstitution following allogeneic hematopoietic stem cell transplantation	31
Associations between geography, decision‐making style, and interest in cancer clinical trial participation	30
Beyond the PSA: The hidden costs of screening in prostate cancer	30
Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia	30
Prostate cancer in Black men responds better to immunotherapy	30
Keep moving to prevent cancer	30
Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?	30
Cancer‐related impairments and functional limitations among long‐term cancer survivors: Gaps and opportunities for clinical practice	30
Issue Information	29
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5	29
Select cases might get a benefit from chemotherapy for Stage I pT1aN0M0 HER2+ breast cancer	29
Lost in the shadow of giants: The neglected treatment modalities in oncologic trials	29
Issue Information	29
Peripheral blood parameter abnormalities precede therapy‐related myeloid neoplasms after autologous transplantation for lymphoma	29
The use of national datasets to evaluate outcomes for invasive lobular carcinoma	28
Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancer	28
Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicente	28
Issue Information	28
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance	28
	28
Cervical cancer elimination in Indian context: Moving from barriers to facilitators	27
Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study	27
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT–confirmed complete response	27
Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life	27
Safety, efficacy, and pharmacokinetics of SH‐1028 in EGFR T790M‐positive advanced non–small cell lung cancer patients: A dose‐escalation phase 1 study	27
Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer	26
Effect of preoperative programmed death‐1 or programmed death ligand‐1 immune check point inhibition on complications after surgery for primary head and neck cancer	26
A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment	26
Triple‐negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding	26
Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study	26
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma	26
Impact of acupuncture and integrative therapies on chemotherapy‐induced peripheral neuropathy: A multicentered, randomized controlled trial	26
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma	26
Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions	26
	25
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: “Repeat and replicate”	25
Helping patients with cancer to understand secondary findings on genetic tests	25
Continuity and coordination of care for childhood cancer survivors with multiple chronic conditions: Results from the Childhood Cancer Survivor Study	25
Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 study	25
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease	25
Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial	25
Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression	25
From childhood cancer to metabolic syndrome	25
Making a case for del(1p) as a high‐risk abnormality in multiple myeloma	25
	24
Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B‐cell lymphoma	24
Increased health‐related quality of life impairments of male and female survivors of childhood cancer: DCCSS LATER 2 psycho‐oncology study	24
Young adult males have worse survival than females that is largely independent of treatment received for many types of central nervous system tumors: A National Cancer Database analysis	24
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial	24
Real‐world treatment patterns and outcomes with oral azacitidine maintenance therapy in patients with acute myeloid leukemia	24
The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative	24
A call to action to advance patient‐focused and decentralized clinical trials	24
Fecal microbiota transplantation for immunotherapy‐resistant urological tumors: Is it time? An update of the recent literature	24
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis	24
Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study	23
Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations	23
A randomized prospective trial of an ostomy telehealth intervention for cancer survivors	23
Associations between experiences of discrimination and quality of life in Black breast cancer survivors	23
Seroconversion and outcomes after initial and booster COVID‐19 vaccination in adults with hematologic malignancies	23
Standard of care for children with newly diagnosed B‐cell ALL	23
Issue Information	22
Correlation analysis of invasive disease‐free survival and overall survival in a real‐world population of patients with HR+/HER2– early breast cancer	22
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma	22
A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers	22
Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer	22
The American Cancer Society National Lung Cancer Roundtable strategic plan: Introduction	22
	22
Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors	22
Anti‐Müllerian hormone for assessing ovarian toxicity of cancer treatment in young women: It’s complicated	22
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era	22
Olaparib in treatment‐refractory isocitrate dehydrogenase 1 (IDH1)– and IDH2‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 tri	22

Reply to “Another look at floor and ceiling effects in the EORTC QLQ‐C30 Physical Functioning subscale and possible solutions”	22
Liver transplantation for hepatic epithelioid hemangioendothelioma	22
First person profile: Robert C. Bast Jr MD	21
Preclinical data suggest role of dopamine in preventing select skin cancers	21
Disease characteristics and mortality among Asian women with breast cancer	21
Palliative care training can help patients with advanced cancer at the end of life	21
Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020)	21
Lung cancer screening associated with earlier diagnosis and improved survival	21
Cancer treatment in the time of COVID‐19 pandemics: A new concern	21
An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry	21
Reasons for refusal of the human papillomavirus vaccine among young cancer survivors	21
The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment–driven intervention study	21
Cannabis use among adults undergoing cancer treatment	20
Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?	20
Defining disease modification in myelofibrosis in the era of targeted therapy	20
	20
Association between exposures to radon and γ‐ray radiation and histologic type of lung cancer in Eldorado uranium mining and milling workers from Canada	20
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study	20
Top advances of the year: Targeted therapy for lung cancer	20
Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single‐arm, prospective phase 2 study	20
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study	20
Alarming recent rises in early‐onset colorectal cancer	20
A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas	20
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study	20
Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort	20
Cyclin‐dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple‐negative breast cancer by affecting the immune microenvironment	20
Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years	20
Effects by educational attainment of a mammography screening patient decision aid for women aged 75 years and older	20
The rising burden of cancer in low– and middle–Human Development Index countries	19
AACR 2024 presents advancements in pancreatic and gastric cancers	19
Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04	19
First person profile: Fadlo R. Khuri, MD	19
Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high‐risk population: A cross‐sectional study	19
Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group	19
Oncologists’ role in end‐of‐life chemotherapy and patient‐centered care	19
Issue Information	19
Hepatocellular carcinoma, vascular endothelial growth factor receptors‐targeting agents, and hypertension: A much more complicated relationship than expected	19
Cancer screenings should resume says coalition of 76 organizations	19
An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool	19
Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study	19
Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial	19
Erratum to “Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children’s Oncology Group”	19
CD123 expression linked to high‐risk disease in children with acute myeloid leukemia	19
Association of mental health diagnosis with race and all‐cause mortality after a cancer diagnosis: Large‐scale analysis of electronic health record data	19
Multidimensional structural racism and estimated cancer risk from traffic‐related air pollution	18
Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology	18
Is repeat breast conservation possible for small ipsilateral breast cancer recurrence?	18
Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021	18
Top advances of the year in colorectal cancer	18
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study	18
A prospective study on diagnostic accuracy of technology‐enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India	18
Breast health equity along the cancer care continuum: A collaborative grant initiative	18
Implementation and evaluation of a remote geriatric assessment and intervention program in Brazil	18
Gaps in care highlight the need to expand access to clinical cancer trials	18
Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trial	18
Glioma mutational signatures associated with haloalkane exposure are enriched in firefighters	18
The impact of the COVID‐19 pandemic on African American cancer survivors	18
Erratum to “Use of a clinical trial screening tool to enhance accrual”	17
The cost burden of metastatic prostate cancer in the US populations covered by employer‐sponsored health insurance	17
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry	17
	17
	17
	17
	17
The American Cancer Society National Lung Cancer Roundtable strategic plan: Advancing comprehensive biomarker testing in non–small cell lung cancer	17
Cumulative incidence and risk factors of brain metastases in metastatic non–small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IM	17
Disparities in phase 1 cancer clinical trial enrollment	17
Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients	17
Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III–IVa cervical cancer: is the ENGOT‐cx11/GOG‐3047/KEYNOTE‐A18 trial practice changing?	17
Genomics likely are not the main driver in advanced prostate cancer overall survival rate disparities	17
Systemic therapies at the end of life vary by patient and practice	17
	17
Association between the amount of artificial hydration and quality of dying among terminally ill patients with cancer: The East Asian Collaborative Cross‐Cultural Study to Elucidate the Dying Process	17
Geographic diffusion of digital mammography in the United States	17
Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors	17
Generalizing approaches to surveillance for complex social outcomes in broad‐range patient populations—The cost in terms of lost information and subgroup utility	17
	17
Cancer survivors have an increased risk of cardiovascular disease	16
Reply to “Vitamin D and breast cancer: Stop torturing the data!”	16
Air pollution was high centuries before industrial revolutions and may have been responsible for cancer rates in medieval Britain	16
Cancer registries: A look back and forward	16
Top advances of the year: Cervical cancer	16
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies	16
Issue Information	16
Reply to “How should decision aids be developed, and which patient outcomes should be assessed?”	16
Insulin resistance during androgen deprivation therapy in men with prostate cancer	16
First person profile: Julie Brahmer, MD	16
Issue Information	16
Issue Information	16
Chronic conditions, cancer disparities, and the unique needs of Black women with ovarian cancer	16
Social relationships and their impact on health‐related quality of life in a long‐term breast cancer survivor cohort	16
Locus‐of‐care disparities in end‐of‐life care intensity among adolescents and young adults with cancer: A population‐based study using the IMPACT cohort	16
Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a survey	16
Sexual health in adult survivors of childhood cancer: A Project REACH study	16
Issue Information	16